IRADIMED CORP — Director's Dealing 2021

Jul 13, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2021-07-08

Reporting Person: Scott Christopher K. (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-08	Restricted Stock Units	$	A	5084	Acquired		Common Stock (5084)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.

F2: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in over four years in annual installments, each equal to 25% of the RSU Grant, with the first installment vesting twelve (12) months from the effective date, July 8, 2021, and the second, third and fourth installments vesting respectively 24, 36 and 48 months from the effective date, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.